Professional
Added to YB: 2026-05-22
Pitch date: 2026-04-10
ABT [neutral]
Abbott Laboratories
-11.79%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.
Market Cap
$153.9B
Pitch Price
$99.50
Price Target
N/A
Dividend
2.85%
EV/EBITDA
14.95
P/E
24.76
EV/Sales
4.02
Sector
Health Care Equipment and Supplies
Category
dividend
Show full summary:
Alpha Wealth Funds Portfolio Holding: Abbott Laboratories
ABT (holding update): Dividend King down 7.5% post-Q1 miss, near 52W low ~$101. CEO Ford bought $2M at $107, Director Starks $1M at $109. FreeStyle Libre 3 Class 1 recall priced in. Exact Sciences integration adds MCED cancer diagnostic to robust line. Trading ~7% below entry; plan to add more.
Read full article (1 min)